Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

Overview of attention for article published in Frontiers in oncology, March 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Readers on

mendeley: 1 Mendeley

Summary X Reddit

So far, Altmetric has seen 1 Reddit thread.

Frontiers | Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

User WalkingHorse, in the LungCancerSupport subreddit, 25 Mar 2024

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.